Advertisement
Advertisement
TEVA
Teva Pharmaceutical Industries Limited - ADR
33.24
USDSponsored
-1.41
-4.07%
Jul 08, 16:00 UTC -4
Closed
After-Market
33.75
+0.51
+1.53%
TEVA Earnings Reports
Positive Surprise Ratio
TEVA beat 15 of 30 last estimates.
50%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.15B
/$0.62
Implied change from Q1 26 (Revenue/ EPS)
+4.16%
/+16.98%
Implied change from Q2 25 (Revenue/ EPS)
-0.68%
/-6.06%
Teva Pharmaceutical Industries Limited - ADR earnings per share and revenue
On Apr 29, 2026, TEVA reported earnings of 0.53 USD per share (EPS) for Q1 26, beating the estimate of 0.48 USD, resulting in a 8.78% surprise. Revenue reached 3.98 billion, compared to an expected 3.89 billion, with a 2.48% difference. The market reacted with a +11.89% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.62 USD, with revenue projected to reach 4.15 billion USD, implying an increase of 16.98% EPS, and increase of 4.16% in Revenue from the last quarter.
FAQ
What were Teva Pharmaceutical Industries Limited - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Teva Pharmaceutical Industries Limited - ADR reported EPS of $0.53, beating estimates by 8.78%, and revenue of $3.98B, 2.48% above expectations.
How did the market react to Teva Pharmaceutical Industries Limited - ADR's Q1 2026 earnings?
The stock price moved up 11.89%, changed from $31.62 before the earnings release to $35.38 the day after.
When is Teva Pharmaceutical Industries Limited - ADR expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Teva Pharmaceutical Industries Limited - ADR's next earnings report?
Based on 4
analysts, Teva Pharmaceutical Industries Limited - ADR is expected to report EPS of $0.62 and revenue of $4.15B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement